Skip to Main Content

Paper Details

Real-world Clinical Outcomes of Bebtelovimab and Sotrovimab Treatment of High-risk Persons With Coronavirus Disease 2019 During the Omicron Epoch.
Open Forum Infect Dis
15
2022

Datasets

Release 1.2